AXIN1 and colorectal carcinoma: To evaluate the destruction complex of beta-catenin by the expression of beta-catetenin, adenomatous polyposis coli, glycogen synthase kinase 3β, axin, and ubiquitin proteins in colorectal carcinoma and colonic adenoma.